-

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

  • Enhanced Smart Food Logging experience now provides nutritional breakdown of meals
  • Advanced AI-enabled features will deliver easy meal tracking to transform daily metabolic health management
  • Redesigned and personalized Daily Insights will reveal how daily performance and behaviors impact health

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take steps in achieving their long-term health goals. The newest features will launch nationwide in the coming weeks.

Last year, Dexcom introduced AI-driven Smart Food Logging in Stelo, the first over-the-counter glucose biosensor cleared1 by the FDA in the United States. Now the company has expanded this feature by integrating a comprehensive nutrition database that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more, for each logged meal, helping users better understand how food impacts their glucose and empowering them to make more informed dietary decisions. The database includes over one million food options with multiple ways to log a meal, including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution.

“When we launched Smart Food Logging last summer, our goal was to provide users with a simple and effective way to consistently log meals and understand how those meals had an impact on their glucose,” said Girish Naganathan, executive vice president and chief technology officer at Dexcom. “We listened closely to the feedback and are excited to further enhance this highly requested feature in Stelo. The latest update will eliminate nutrition tracking friction so users can make informed, health-conscious decisions and achieve health goals with even greater confidence.”

Understanding the role of macronutrients such as carbohydrates, proteins, and fats is essential for maintaining healthy glucose levels. After using Stelo for 30 days, the majority of users indicated positive changes in their dietary and eating patterns, and improvements in physical activity and weight-management habits.2,3 By learning how different foods and specific macronutrients impact glucose levels with Stelo, users will be empowered with even more information to better understand and manage their metabolic health.

"Living with type 2 diabetes has forced me to slow down and pay attention to my health," said Mike Golic Sr., sports broadcaster, former professional football defensive tackle and Stelo ambassador. "Before Stelo, I was guessing how different foods affected my glucose—now I actually know. What excites me most about the latest update to Smart Food Logging is that it’s going to make managing my health even more seamless. This isn't just about better technology—it's about giving people the information to stay ahead of their metabolic health instead of always playing catch-up.”

Stelo will also launch a redesigned Daily Insights feature which will introduce a new interface with a sophisticated, card-based system. Users will receive up to three personalized recommendations based on their previous day's glucose, activity, nutrition, and sleep data. Each insight will highlight key individual metrics and provide contextual understanding.

A fourth card will use behavioral science techniques to help users reflect on and act upon their metabolic health insights. The feature uses AI to maintain day-over-day context, ensuring consistent and evolving personalized coaching that adapts to individual patterns and progress.

Stelo users will be able to access the enhanced Smart Food Logging and redesigned Daily Insights features by updating to the latest version of the app* on iOS and Android platforms in the coming weeks.

Dexcom is bringing these new features to Stelo as it finishes development and regulatory approvals for a completely reimagined Stelo app experience, launching later this year.

To learn more about Stelo or to purchase, visit Stelo.com or Amazon.

About Dexcom

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

*Smart device sold separately. For Stelo app compatibility information, visit stelo.com/compatibility.

1 Dexcom, Stelo User Guide, 2024. 2 Crawford, M. (2025). Early Experiences with Stelo: Real-World Behavioral and Glycemic Outcomes in Users with Type 2 Diabetes, Prediabetes, or No Diabetes [Conference presentation abstract]. Eighty-Fifth scientific sessions of the American Diabetes Association, Chicago, IL, United States. https://doi.org/10.2337/db25-2020-LB 3 Dexcom, Data on File, 2025.

Category: IR

Contacts

Media Contact
Janika Kelly
mediarelations@dexcom.com

Investor Contact
Sean Christensen
sean.christensen@dexcom.com

Dexcom, Inc.

NASDAQ:DXCM

Release Versions

Contacts

Media Contact
Janika Kelly
mediarelations@dexcom.com

Investor Contact
Sean Christensen
sean.christensen@dexcom.com

More News From Dexcom, Inc.

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of Dexcom G7 leads to clinically and statistically significant reduction in A1C and improvement in glucose control among people with Type 2 diabetes not using insulin compared with a routine care control group using self-monitoring of blood glucose.1 Researchers presented these results today as an oral presentation at the 2026 Scientific Sessions of...

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) will present new clinical findings, product advancements and strategic business initiatives reinforcing its commitment to improving care for people with all types of diabetes and ushering in a new era of early stage CGM intervention and preventative care at the American Diabetes Association’s Scientific Sessions in New Orleans, June 5-8, 2026. “Dexcom has built a legacy of innovation within the diabetes space and as we look to the future, e...

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc., the global leader in glucose biosensing, today released its inaugural Customer Advisory Council Report, detailing candid feedback from users, caregivers, healthcare professionals and community leaders, along with clear, actionable company commitments to further elevate product performance and user experience. Building on its position as the manufacturer of the most accurate CGM systems1, Dexcom continues to listen, innovate and act on customer insights...
Back to Newsroom